| Trial Status | Recruiting |
| Dates | Date of activation: 18-May-09 |
| Data management at EORTC | Full |
| Phase | 3 |
| Randomized trial | Yes |
| Type | Adjuvant |
| Targeted Sample size | EORTC Groups: 600 - All Groups: 600 |
| Number of steps | 1 |
| Drug | Leuprorelin |
| Study Staff | Michel Bolla (Study Coordinator) - CHU de Grenoble - La Tronche - Hôpital A. Michallon, Grenoble Steven Joniau (Study Coordinator) - U.Z. Leuven - Campus Gasthuisberg, Leuven Laurence Collette (Statistician) - EORTC Headquarters, Brussels Isabelle Meulders (Data Manager) - EORTC Headquarters, Brussels Denis Lacombe (Coordinating Physician) - EORTC Headquarters, Brussels Anne Kirkpatrick (Project Manager) - EORTC Headquarters, Brussels, anne.kirkpatrick( at )eortc.be, +32 27741691 |
| Type of cancer | Prostate |
| Participating Groups | EORTC Radiation Oncology Group(Coordinating Group) EORTC Genito-Urinary Cancers Group |
| Centers authorized by EORTC | Hôpitaux Universitaires Bordet-Erasme - Institut Jules Bordet (Brussels, Belgium) - Inst. 101 Universitair Ziekenhuis Gent (Gent, Belgium) - Inst. 104 Cliniques Universitaires St. Luc (Brussels, Belgium) - Inst. 121 U.Z. Leuven - Campus Gasthuisberg (Leuven, Belgium) - Inst. 147 AZ Turnhout - Campus Sint Elisabeth (Turnhout, Belgium) - Inst. 151 AZ Groeninge Kortrijk - Campus Vercruysselaan (Kortrijk, Belgium) - Inst. 156 Hopital De Jolimont (Haine St Paul, Belgium) - Inst. 474 Clinique et Maternité Sainte Elisabeth (Namur, Belgium) - Inst. 1201 Virga Jesse Hospital (Hasselt, Belgium) - Inst. 1217 Algemeen Ziekenhuis Sint-Augustinus (Wilrijk, Belgium) - Inst. 1234 Bank Of Cyprus Oncology Centre (Strovolos - Nicosia, Cyprus) - Inst. 3607 CHU de Grenoble - La Tronche - Hôpital A. Michallon (Grenoble, France) - Inst. 215 Institut Gustave Roussy (Villejuif, France) - Inst. 225 Centre Leon Berard (Lyon, France) - Inst. 227 Centre Georges-Francois-Leclerc (Dijon, France) - Inst. 229 CHRU de Besancon - Hopital Jean Minjoz (Besancon, France) - Inst. 422 Institut régional du Cancer Montpellier (Montpellier, France) - Inst. 429 Heinrich-Heine Universitaetsklinik Dusseldorf (Duesseldorf, Germany) - Inst. 483 Universitaetsklinikum - Essen (Essen, Germany) - Inst. 509 Charite - Universitaetsmedizin Berlin - Campus Benjamin Franklin (Berlin, Germany) - Inst. 523 Institut Catala d'Oncologia - ICO Badalona - Hospital Germans Trias i Pujol (Institut Catala D'Oncologia) (Badalona - (barcelona), Spain) - Inst. 381 Hospital De Navarra (Pamplona, Spain) - Inst. 938 Hospital Del Mar (Barcelona, Spain) - Inst. 959 Institut Catala d'Oncologia - ICO L’Hospitalet - Hospital Duran i Reynals (Institut Catala D'Oncologia) (L'Hospitalet de Llobregat, Spain) - Inst. 6225 Radio-Onkologie Berner Oberland AG (Thun, Switzerland) - Inst. 9324 Hôpitaux universitaires de Genève - HUG - site de Cluse-Roseraie (Geneve, Switzerland) - Inst. 451 Inselspital (Bern, Switzerland) - Inst. 454 Centre Hospitalier Universitaire Vaudois (Lausanne, Switzerland) - Inst. 457 Ospedale Regionale Bellinzona e Valli (Bellinzona, Switzerland) - Inst. 459 The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis (Amsterdam, The Netherlands) - Inst. 301 Leiden University Medical Centre (Leiden, The Netherlands) - Inst. 310 Isala Klinieken - Locatie Sophia (Zwolle, The Netherlands) - Inst. 328 University Medical Center Groningen (Groningen, The Netherlands) - Inst. 335 Erasmus MC (Rotterdam, The Netherlands) - Inst. 336 Maastro Clinic - Maastricht Radiation Oncology (Maastricht, The Netherlands) - Inst. 4900 |
| Protocol summary | Cancer.gov (PDQ) ClinicalTrials.gov |
| NCT number | NCT00949962 |
| EudraCT | 2006-002772-17 |
| Protocol documents in PDF (requires password) | Study documentation |